{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,19]],"date-time":"2026-08-19T10:33:44Z","timestamp":1787135624003,"version":"build-2736575974"},"reference-count":11,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2019,11,19]],"date-time":"2019-11-19T00:00:00Z","timestamp":1574121600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2019,11,19]],"date-time":"2019-11-19T00:00:00Z","timestamp":1574121600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Pulm Med"],"published-print":{"date-parts":[[2019,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n<jats:title>Background<\/jats:title>\n<jats:p>Eosinophilic lung diseases represent a heterogeneous group of disorders with prominent infiltrate of eosinophils in lung interstitium and alveolar spaces. Peripheral blood eosinophilia is often present. Infections, drugs, allergens, toxic agents have to be evaluated as possible causes of eosinophilic lung infiltrates. The category of myeloid\/lymphoid neoplasms with eosinophilia and rearrangement of PDGFRA, PDGFRB, FGFR1 and PCM1-JAK2 represents an uncommon cause of eosinophilic lung infiltrate.<\/jats:p>\n<\/jats:sec><jats:sec>\n<jats:title>Case presentation<\/jats:title>\n<jats:p>We report the case of a 70-year old man complaining of dry cough and dyspnea. Ground glass-opacities were seen on imaging studies and peripheral blood eosinophilia was present. A thorough step-wise patient\u2019s evaluation led to identify the clonal nature of eosinophilia and the diagnosis of myeloid\/lymphoid neoplasm with eosinophilia and rearrangement of PDGFRA was made.<\/jats:p>\n<\/jats:sec><jats:sec>\n<jats:title>Conclusions<\/jats:title>\n<jats:p>Correlation with clinical history, laboratory tests and imaging studies is essential to achieve the correct diagnosis when facing with eosinophilic lung infiltrates. A prolonged eosinophilia can cause life-threatening organ damage. Identification of PDGFRA rearrangement, as in the present case, is particularly critical given the sensitivity and excellent response to imatinib, which has completely changed the natural history of this neoplasm.<\/jats:p>\n<\/jats:sec>","DOI":"10.1186\/s12890-019-0967-7","type":"journal-article","created":{"date-parts":[[2019,11,19]],"date-time":"2019-11-19T06:03:03Z","timestamp":1574143383000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":13,"title":["A tricky and rare cause of pulmonary eosinophilia: myeloid\/lymphoid neoplasm with eosinophilia and rearrangement of PDGFRA"],"prefix":"10.1186","volume":"19","author":[{"given":"Magda","family":"Zanelli","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maxwell","family":"Smith","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9841-7856","authenticated-orcid":false,"given":"Maurizio","family":"Zizzo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Angelo","family":"Carloni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Riccardo","family":"Valli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Loredana","family":"De Marco","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Moira","family":"Foroni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrea","family":"Palicelli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giovanni","family":"Martino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefano","family":"Ascani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2019,11,19]]},"reference":[{"key":"967_CR1","volume-title":"WHO classification of tumours of haematopoietic and lymphoid tissues, WHO classification of tumours, revised 4th edition, ed","year":"2017","unstructured":"Swerdlow SH, Campo E, Harris NL, Jaffe ES, Pilleri SA, Stein H, et al., editors. WHO classification of tumours of haematopoietic and lymphoid tissues, WHO classification of tumours, revised 4th edition, ed. IARC: World Health Organization; 2017."},{"key":"967_CR2","unstructured":"Jaffe ES, Arber DA, Campo E, Harris NL, Quintanilla-Fend L. Hematopathology, 2nd edition, ed. Elsevier; 2016."},{"issue":"11","key":"967_CR3","doi-asserted-by":"publisher","first-page":"1243","DOI":"10.1002\/ajh.24880","volume":"92","author":"J Gotlib","year":"2017","unstructured":"Gotlib J. World Health Organization-defined eosinophilic disorders: 2017 update on diagnosis, risk stratification, and management. Am J Hematol. 2017;92(11):1243\u201359. https:\/\/doi.org\/10.1002\/ajh.24880.","journal-title":"Am J Hematol"},{"issue":"2","key":"967_CR4","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1111\/ijlh.12955","volume":"41","author":"Rebecca L. Larsen","year":"2018","unstructured":"Larsen RL, Savage NM. How I investigate eosinophilia. Int J Lab Hematol. 2018. https:\/\/doi.org\/10.1111\/ijlh.12955.","journal-title":"International Journal of Laboratory Hematology"},{"issue":"10","key":"967_CR5","doi-asserted-by":"publisher","first-page":"1060","DOI":"10.5858\/arpa.2016-0223-RA","volume":"140","author":"DF Boyer","year":"2016","unstructured":"Boyer DF. Blood and bone marrow evaluation for eosinophilia. Arch Pathol Lab Med. 2016;140(10):1060\u20137. https:\/\/doi.org\/10.5858\/arpa.2016-0223-RA.","journal-title":"Arch Pathol Lab Med"},{"issue":"6","key":"967_CR6","doi-asserted-by":"publisher","first-page":"704","DOI":"10.1182\/blood-2016-10-695973","volume":"129","author":"A Reiter","year":"2017","unstructured":"Reiter A, Gotlib J. Myeloid neoplasms with eosinophilia. Blood. 2017;129(6):704\u201314. https:\/\/doi.org\/10.1182\/blood-2016-10-695973.","journal-title":"Blood."},{"issue":"25","key":"967_CR7","doi-asserted-by":"publisher","first-page":"17406","DOI":"10.1074\/jbc.R113.546218","volume":"289","author":"KR Acharya","year":"2014","unstructured":"Acharya KR, Ackerman SJ. Eosinophil granule proteins: form and function. J Biol Chem. 2014;289(25):17406\u201315. https:\/\/doi.org\/10.1074\/jbc.R113.546218.","journal-title":"J Biol Chem"},{"key":"967_CR8","volume-title":"Tumours of the bone marrow (AFIP atlas of tumour pathology, series 4), ed","author":"K Foucar","year":"2016","unstructured":"Foucar K, McKenna RW, Peterson LC, Kroft SH. Tumours of the bone marrow (AFIP atlas of tumour pathology, series 4), ed. American Registry of Pathology; 2016."},{"issue":"3","key":"967_CR9","doi-asserted-by":"publisher","first-page":"535","DOI":"10.1016\/j.ccm.2016.04.015","volume":"37","author":"V Cottin","year":"2016","unstructured":"Cottin V. Eosinophilic lung diseases. Clin Chest Med. 2016;37(3):535\u201356. https:\/\/doi.org\/10.1016\/j.ccm.2016.04.015.","journal-title":"Clin Chest Med"},{"issue":"05","key":"967_CR10","doi-asserted-by":"publisher","first-page":"555","DOI":"10.1055\/s-0032-1325164","volume":"33","author":"NY Bhatt","year":"2012","unstructured":"Bhatt NY, Allen JN. Update on eosinophilic lung disease. Semin Respir Crit Care Med. 2012;33(05):555\u201371. https:\/\/doi.org\/10.1055\/s-0032-1325164.","journal-title":"Semin Respir Crit Care Med"},{"key":"967_CR11","doi-asserted-by":"publisher","first-page":"690","DOI":"10.1182\/blood-2018-99-110388","volume":"132","author":"S Verstovsek","year":"2018","unstructured":"Verstovsek S, Vannucchi AM, Rambaldi A, Gotlib JR, Mead AJ, Hochhaus A, Kiladjian JJ, Hernandez Boluda JC, Asatiani E, Lihou C, Zhen H, Reiter A. Interim results from Fight-203, a phase 2, open-label, multicenter study evaluating the efficacy and safety of Pemigatinib (INCB054828) in patients with myeloid\/lymphoid neoplasms with rearrangement of fibroblast growth factor receptor 1 (FGFR1). Blood. 2018;132:690. https:\/\/doi.org\/10.1182\/blood-2018-99-110388.","journal-title":"Blood"}],"container-title":["BMC Pulmonary Medicine"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12890-019-0967-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s12890-019-0967-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12890-019-0967-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,11,18]],"date-time":"2020-11-18T03:58:29Z","timestamp":1605671909000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcpulmmed.biomedcentral.com\/articles\/10.1186\/s12890-019-0967-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,11,19]]},"references-count":11,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2019,12]]}},"alternative-id":["967"],"URL":"https:\/\/doi.org\/10.1186\/s12890-019-0967-7","relation":{},"ISSN":["1471-2466"],"issn-type":[{"value":"1471-2466","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,11,19]]},"assertion":[{"value":"20 March 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 October 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 November 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Local ethics committee (Comitato Etico dell\u2019Area Vasta Emilia Nord, Italy) ruled that no formal ethics approval was required in this particular case.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Written informed consent was obtained from patient for publication of this Case Report and any accompanying images. A copy of the written consent is available for review by the Editor-in-Chief of this journal.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare they have no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"216"}}